RECENT NEWS

Roche Diagnostics UK & Ireland has welcomed NICE’s new guidance recommending routine use of placental growth factor (PlGF)-based testing in the NHS in England and Wales to help diagnose suspected pre-eclampsia.

The King’s Fund is hosting a one-day conference in London on 16 November, looking at the future role of diagnostics in the NHS.

Teesside University has announced plans for a new £35m central science and medical building which will provide cutting-edge new laboratories for the sciences and clinical subjects.

A network of drones could soon be playing a vital role in connecting NHS services in Scotland – including pathology laboratories - after the project secured £10.1 million in funding.

‘Point of Care: Innovations’ is a free-to-attend meeting for NHS staff being held in Bristol at The Bristol – Harbourside (Doyle Collection) hotel on 20 September.

Thermo Fisher Scientific has showcased innovative diagnostic technologies, assays and a complement of solutions for researchers developing new diagnostics during AACC 2022 in Chicago.

Merck has opened its first Microbiology Application and Training (MAT) Laboratory in Bangalore, India, with a €200,000 investment.

BIOHIT HealthCare has relaunched its website. This new look and feel is designed to reflect the company’s vision, mission and values, while making it easier than ever for customers and partners to find the information they need.

A new pathology laboratory planned for East Lancashire has prompted a row between senior consultants and the managing director of the Lancashire and South Cumbria Pathology Collaboration, the Lancashire Telegraph has reported.

Paragraf, the first company to deliver a scalable approach to graphene electronic device manufacturing, has announced a plan to develop a new generation of graphene-based, in vitro diagnostic products that will give results within a few minutes.

Citadel Health will reshape connected pathology services across the Birmingham and Solihull area each year after being chosen to implement and operate its innovative laboratory information management system (LIMS) across eight key sites.

The new MetalFree centrifuge tubes, now available in the UK from Alpha Laboratories, are intended for the storage, high-speed centrifugation and analysis of samples requiring ultra-low trace metal contents.

Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, has announced the appointment of Suzanne Foster as president of the company.

Biotium, a supplier and inventor of fluorescent cellular probes for life science research, has announced the release of new ExoBrite Antibody Conjugates.

Scientific Laboratory Supplies (SLS), a leading supplier of equipment, chemicals and consumables for laboratory use in the UK, has announced the acquisition of Gem Scientific and Northern Balance, to expand its product and service offerings.

Torrey Pines Scientific has announced its EchoTherm RIC40 Peltier-driven, compact Chilling/Heating Dry Baths with temperatures settable from 0C to 100C, for use with robotic systems. They are controlled via the RS232 I/O port on each RIC40 unit.

ARKRAY has launched the AUTION AI-4510, an advanced automated urine sediment analyser with inbuilt features to speed up workflow. It is the only sediment system to offer onboard autodilution, removing waste and ensure a higher degree of accuracy.

NADMED has launched two kits, Q-NADMED and Q-NAD. Q-NADMED is the first kit available for whole blood NAD+ and NADH analysis; the first CE-marked kit for NAD analysis; and the only EU IVDD-compliant kit for NAD+ and NADH analysis from blood.

SPT Labtech, a leader in the design and development of automated instrumentation and consumables, has announced its acquisition by EQT IX Fund (EQT Private Equity), a purpose-driven global investment organisation, from current owners Battery Ventures.

Bio-Rad Laboratories has extended its range of recombinant monoclonal anti-idiotypic antibodies to include those specific to brentuximab vedotin (Adcetris), secukinumab (Cosentyx), and the secukinumab–interleukin 17A (IL-17A) drug-target complex.